RAC 7.61% $1.70 race oncology ltd

Ann: Expanded Heart Protection Discovery for Zantrene, page-357

  1. 5,102 Posts.
    lightbulb Created with Sketch. 3093
    It’s covid. The viruses inflammatory effects.

    Require a much longer explanation and quoting of extensive data, & a lot of answering - but this is the short and important answer.
    I would not be having a covid vaccine shortly after having covid-19 though, when the heart can be inflamed. (wait 6+ months and questionable to be necessary after omicron infection now. )

    But the virus is the significant risk and issue for heart inflammation and organ damage. Vaccination is our no1 defence & hopefully ongoing vaccine developments yes.

    It is interesting to contemplate how Zantrene even - that Zantrene could be a very effective treatment for where there are risks of enduring covid infection or long- covid. And cardio protection effects.

    It is simply too much to investigate right now but not inconceivable.
    Bisantrene came up as one of the top 20 drugs from database globally as a possible covid- 19 treatment (early in the pandemic, in 2020, FYI. )
    Someone here could probably find the original posts regarding this.

    Last edited by Aqua65: 28/03/22
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.